To Assess the Beneficial Effects of Rosuvastatin Before Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome. (2024). Medical Forum Monthly, 30(10). https://medicalforummonthly.com/index.php/mfm/article/view/4945